The proteasome inhibitor bortezomib enhances the activity of docetaxel in orthotopic human pancreatic tumor xenograftsSteffan T. Nawrocki, David J. McConkey, Bridget Sweeney‐Gotsch et al.|Molecular Cancer Therapeutics|2004Cited by 134